Reviva Pharmaceuticals (RVPHW) Competitors $0.16 +0.01 (+7.33%) As of 01/30/2025 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends RVPHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Reviva Pharmaceuticals stock or one of its competitors? The main competitors of Reviva Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Reviva Pharmaceuticals vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Reviva Pharmaceuticals (NASDAQ:RVPHW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Does the media prefer RVPHW or ATNFW? In the previous week, Reviva Pharmaceuticals had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Reviva Pharmaceuticals and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Reviva Pharmaceuticals' score of 1.44 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Reviva Pharmaceuticals Positive 180 Life Sciences Very Positive Does the MarketBeat Community prefer RVPHW or ATNFW? Reviva Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformReviva PharmaceuticalsN/AN/A180 Life SciencesN/AN/A Which has stronger valuation & earnings, RVPHW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReviva PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is RVPHW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Reviva PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryReviva Pharmaceuticals and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPHW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVPHW vs. The Competition Export to ExcelMetricReviva PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$178.34M$5.61B$9.14BDividend YieldN/A3.64%5.36%3.98%P/E RatioN/A138.2789.6917.66Price / SalesN/A18,255.231,219.4081.09Price / CashN/A13.0144.3437.71Price / BookN/A8.975.134.73Net IncomeN/A-$20.89M$118.85M$225.42M7 Day Performance-16.15%7.72%1.39%0.75%1 Month Performance-2.07%9.96%7.52%3.61%1 Year Performance-83.90%108.34%26.67%21.42% Reviva Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVPHWReviva PharmaceuticalsN/A$0.16+7.3%N/A-83.6%$0.00N/A0.005Short Interest ↓Positive NewsGap UpATNFW180 Life SciencesN/A$0.01+2.3%N/A+136.8%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03-1.0%N/A-30.0%$0.00N/A0.002AIMDWAinosN/A$0.10-43.3%N/A+198.3%$0.00$40,633.000.0040ALVOWAlvotechN/A$2.84-3.4%N/A-30.3%$0.00$391.87M0.004Short Interest ↓Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06flatN/AN/A$0.00N/A0.004BFRIWBiofronteraN/A$0.06-1.1%N/AN/A$0.00$35.36M0.0070BTMDWbioteN/A$0.44-11.2%N/AN/A$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.14+0.1%N/A-90.0%$0.00N/A0.008Short Interest ↑CELUWCelularityN/A$0.06-21.0%N/A+157.8%$0.00$48.20M0.00220High Trading Volume Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RVPHW) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
